Table 3. Univariate logistic regression analysis of the overall response rate in patients treated with first-line tamoxifen and in patients treated with first-line chemotherapy for recurrent disease.
| Study cohort | N Patients | Univariate analysis | |
|---|---|---|---|
| OR (95% CI) | P-value | ||
| First-line tamoxifen | |||
| All patients | 329 | 0.88 (0.69–1.13) | 0.31 |
| First-line chemotherapy | |||
| All patients | 224 | 0.96 (0.71–1.31) | 0.80 |
| CMF-treated patients | 75 | 1.25 (0.70–2.21) | 0.45 |
| Anthracyclin-treated patients | 149 | 0.79 (0.53–1.16) | 0.22 |
N, number of; OR, odds ratio; CI, confidence interval; CMF, cyclophosphamide/methotrexate/5-fluorouracil.
Note: the type of response was ambiguous for 2 patients